Eleusis Announces Notice of Allowance for US Patent Application with Claims Covering Lead Drug Candidate ELE-Psilo
Eleusis Holdings Ltd announced today it has received a Notice of Allowance for its proprietary psilocin salt form and accompanying formulations from the US Patent and Trademark Office. This salt form
Source: finanznachrichten.de